Atlas Trials

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Clinical trial NCT05440227 · RECRUITING

Trial details

NCT number
NCT05440227
Sponsor
PhytoHealth Corporation
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer-related Fatigue
Start date
2023-05-17
Primary completion
2025-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.